MoonLake Immunotherapeutics (MLTX)
43.85
-0.67
(-1.50%)
USD |
NASDAQ |
May 07, 10:42
MoonLake Immunotherapeutics 1 Year Total Returns (Daily): 65.44% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 65.44% |
| May 03, 2024 | 99.82% |
| May 02, 2024 | 102.1% |
| May 01, 2024 | 88.72% |
| April 30, 2024 | 92.07% |
| April 29, 2024 | 96.10% |
| April 26, 2024 | 104.5% |
| April 25, 2024 | 106.2% |
| April 24, 2024 | 77.83% |
| April 23, 2024 | 99.54% |
| April 22, 2024 | 89.25% |
| April 19, 2024 | 93.09% |
| April 18, 2024 | 93.99% |
| April 17, 2024 | 105.2% |
| April 16, 2024 | 128.5% |
| April 15, 2024 | 129.2% |
| April 12, 2024 | 122.2% |
| April 11, 2024 | 117.8% |
| April 10, 2024 | 125.7% |
| April 09, 2024 | 121.8% |
| April 08, 2024 | 119.5% |
| April 05, 2024 | 132.3% |
| April 04, 2024 | 141.9% |
| April 03, 2024 | 122.9% |
| April 02, 2024 | 120.9% |
| Date | Value |
|---|---|
| April 01, 2024 | 127.2% |
| March 28, 2024 | 120.5% |
| March 27, 2024 | 116.7% |
| March 26, 2024 | 138.2% |
| March 25, 2024 | 146.1% |
| March 22, 2024 | 144.7% |
| March 21, 2024 | 137.9% |
| March 20, 2024 | 132.2% |
| March 19, 2024 | 118.6% |
| March 18, 2024 | 109.9% |
| March 15, 2024 | 132.6% |
| March 14, 2024 | 121.1% |
| March 13, 2024 | 102.4% |
| March 12, 2024 | 115.7% |
| March 11, 2024 | 120.5% |
| March 08, 2024 | 92.45% |
| March 07, 2024 | 99.30% |
| March 06, 2024 | 103.6% |
| March 05, 2024 | 118.5% |
| March 04, 2024 | 122.0% |
| March 01, 2024 | 154.6% |
| February 29, 2024 | 151.4% |
| February 28, 2024 | 196.0% |
| February 27, 2024 | 192.8% |
| February 26, 2024 | 189.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-53.10%
Minimum
May 16 2022
998.7%
Maximum
Jul 18 2023
180.6%
Average
22.00%
Median
Jan 05 2023
1 Year Total Returns (Daily) Benchmarks
| Qiagen NV | -7.53% |
| LENZ Therapeutics Inc | -- |
| AC Immune SA | 15.11% |
| CRISPR Therapeutics AG | 2.31% |
| Addex Therapeutics Ltd | -37.09% |